Cargando…

The Improbability of the Rapid Development of a Vaccine for SARS-CoV-2

Detalles Bibliográficos
Autor principal: Morris, Kevin V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291966/
https://www.ncbi.nlm.nih.gov/pubmed/32533920
http://dx.doi.org/10.1016/j.ymthe.2020.06.005
_version_ 1783546006797811712
author Morris, Kevin V.
author_facet Morris, Kevin V.
author_sort Morris, Kevin V.
collection PubMed
description
format Online
Article
Text
id pubmed-7291966
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Society of Gene & Cell Therapy
record_format MEDLINE/PubMed
spelling pubmed-72919662020-06-12 The Improbability of the Rapid Development of a Vaccine for SARS-CoV-2 Morris, Kevin V. Mol Ther Editorial American Society of Gene & Cell Therapy 2020-07-08 2020-06-12 /pmc/articles/PMC7291966/ /pubmed/32533920 http://dx.doi.org/10.1016/j.ymthe.2020.06.005 Text en © 2020 The American Society of Gene and Cell Therapy.
spellingShingle Editorial
Morris, Kevin V.
The Improbability of the Rapid Development of a Vaccine for SARS-CoV-2
title The Improbability of the Rapid Development of a Vaccine for SARS-CoV-2
title_full The Improbability of the Rapid Development of a Vaccine for SARS-CoV-2
title_fullStr The Improbability of the Rapid Development of a Vaccine for SARS-CoV-2
title_full_unstemmed The Improbability of the Rapid Development of a Vaccine for SARS-CoV-2
title_short The Improbability of the Rapid Development of a Vaccine for SARS-CoV-2
title_sort improbability of the rapid development of a vaccine for sars-cov-2
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291966/
https://www.ncbi.nlm.nih.gov/pubmed/32533920
http://dx.doi.org/10.1016/j.ymthe.2020.06.005
work_keys_str_mv AT morriskevinv theimprobabilityoftherapiddevelopmentofavaccineforsarscov2
AT morriskevinv improbabilityoftherapiddevelopmentofavaccineforsarscov2